Angiocrine Bioscience

Therapeutics based on genetically modified endothelial cells

placeSan Diego, California, United States calendar_todayFounded 2012 groups29 employees language angiocrinebioscience.com

Registered entities

Innovation

13 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 646 times.

YearFilings
20151
20162
20175
20186
20196
20205
20218
20225
20235
20247
20253
20262

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon